Related Experiment Videos
The irritable bowel syndrome.
1Division of Gastroenterology, Department of Medicine, University of Michigan Medical Center, 3912 Taubman Center, Box 0362, Ann Arbor, MI 48109, USA. whasler@umich.edu
The Medical Clinics of North America
|January 4, 2003
Summary
Irritable Bowel Syndrome (IBS) is common, with multifactorial causes affecting the gut and nervous system. Diagnosis relies on symptoms, and treatment targets specific subtypes using diet, counseling, and medications.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Psychosomatic Medicine
Background:
- Irritable Bowel Syndrome (IBS) is a prevalent gastrointestinal disorder.
- A significant portion of individuals with IBS seek medical attention due to symptom severity and psychological factors.
- IBS pathogenesis is complex, involving interactions between the gut, immune system, enteric nervous system, and central nervous system (CNS).
Purpose of the Study:
- To summarize the current understanding of Irritable Bowel Syndrome (IBS) diagnosis and management.
- To highlight the multifactorial nature of IBS and its impact on patient care.
- To discuss current and emerging therapeutic strategies for IBS.
Main Methods:
- Diagnosis of IBS is based on Rome criteria symptomatology.
- Exclusion of alarm findings suggestive of organic disease is crucial for diagnosis.
- Therapeutic approaches are guided by the predominant symptom (IBS subtype).
Main Results:
- IBS is diagnosed using symptom-based criteria (Rome criteria).
- Minimal diagnostic testing is recommended for typical IBS presentations.
- Treatment options encompass dietary changes, counseling, pharmacotherapy, and psychological interventions.
Conclusions:
- IBS is a common condition with complex pathophysiology.
- Current management strategies are tailored to IBS subtypes.
- Ongoing research focuses on novel therapies targeting peripheral and CNS abnormalities in IBS.